e-learning
resources
Virtual 2020
Pre-Congress Content
Experimental and laboratory studies in intensive care unit medicine
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of I:E ratio on the respirable delivered dose from nebulizers
A. Metcalf (Chichester (West Sussex), United Kingdom), D. Von Hollen (Murraysville, United States of America), S. Cowley (Chichester (West Sussex), United Kingdom), L. Slator (Chichester (West Sussex), United Kingdom), L. Hardaker (Chichester (West Sussex), United Kingdom)
Source:
Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine
Session:
Experimental and laboratory studies in intensive care unit medicine
Session type:
E-poster session
Number:
2757
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Metcalf (Chichester (West Sussex), United Kingdom), D. Von Hollen (Murraysville, United States of America), S. Cowley (Chichester (West Sussex), United Kingdom), L. Slator (Chichester (West Sussex), United Kingdom), L. Hardaker (Chichester (West Sussex), United Kingdom). Effect of I:E ratio on the respirable delivered dose from nebulizers. 2757
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effect of I:E ratio on delivery of colistimethate sodium from breath-enhanced and breath-activated nebulizers
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Optimization of inhalation treatment – Evaluation of influence of spacer integrated with the spirometer on aerosol particle distribution from pMDI-EB
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010
Effects on the respirable dose < 3.3 µm of an isotonic DSCG inhalation solution (IsoCROM) comparing different nebuliser systems mimicking 3 year old childrens' breathing patterns
Source: Eur Respir J 2007; 30: Suppl. 51, 460s
Year: 2007
Evaluation of delivered dose and treatment time of several mesh nebulizers under in vitro simulated use
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system]
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010
Do dry powder inhalers (DPIs) have a ‘Goldilocks Zone’ of inhalation? In vitro lung deposition of Budesonide/Formoterol (BUD/FORM) DPI with different inhalation profiles
Source: International Congress 2017 – Pulmonary drug and devices delivery
Year: 2017
The impact of different valved holding chambers (VHCs) on lung drug delivery: using functional respiratory imaging (FRI) and a single metered dose inhaler (MDI) type
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
Variability of budesonide (BUD) fine particle dose (FPD) delivered through two multiple dose dry powder inhalers (MDPI)
Source: Eur Respir J 2004; 24: Suppl. 48, 582s
Year: 2004
Effect of changes in peak inspiratory flow on the dose of salbutamol delivered by nebulizers under simulated conditions
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018
Sub-microgram dose formulations for dose ranging studies with long acting bronchodilators and their fixed dose combination using metered dose inhalers (MDIs)
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
A novel breath-actuated vortex spacer device increases respirable dose delivery of fluticasone/salmeterol in combination
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008
Effect of breath-actuated mechanism on the emitted particle characteristics and lung deposition of a fixed combination drug
Source: International Congress 2017 – Inhalers and their use
Year: 2017
Ex-vivo emitted dose characteristics for combination formulations in dry powder inhalers (DPI)
Source: Eur Respir J 2003; 22: Suppl. 45, 472s
Year: 2003
Dose proportionality of
in vitro
fine particle dose for dry powder inhaler combination products
Source: Eur Respir J 2002; 20: Suppl. 38, 541s
Year: 2002
Effect of 3 different nebulisers on the aerosol delivery performance of isotonic disodium comoglycate (IsoCROM)
Source: Eur Respir J 2006; 28: Suppl. 50, 212s
Year: 2006
Does reduced dose volume impact inhaled mass with a novel low residual volume nebulizer?
Source: Eur Respir J 2003; 22: Suppl. 45, 147s
Year: 2003
Effect of device and formulation on delivery of budesonide suspensions by nebulizers
Source: Eur Respir J 2002; 20: Suppl. 38, 542s
Year: 2002
Effect of nebuliser position on aerosol performance during high flow nasal therapy
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018
Delivered dose and fine particle dose of aclidinium bromide 200 µg via the Genuair® inhaler are independent of flow rate within the working range of the device
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010
In vitro aerosol delivery by vibrating mesh nebulizer (VMN) and pressurized metered dose inhaler (pMDI) using spacers in comparison with T adapters in mechanical ventilation.
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept